I've formed the assumption that the drug is safe which is why it'saccessible via SAS. it is benefiting patients but to what degree and the measuring parameters I am unsure....... we know it has a 36% reduction in proteins in urine. let's hope for a few big weeks and some excellent results. really want to be a part of this as it goes into phase 3 and develops into a commercial product.
DMX200 competition including SGLT2 Inhibitors, page-9
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.0¢ |
Change
-0.020(4.44%) |
Mkt cap ! $247.7M | |||
| Open | High | Low | Value | Volume |
| 43.5¢ | 43.8¢ | 42.0¢ | $291.8K | 679.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 137256 | 42.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 41487 | 4 |
View Market Depth
| Last trade - 10.17am 04/09/2024 (20 minute delay) ? |
| DXB (ASX) Chart |